European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 136, Issue 2 , Pages 151-154 , February 2008

Current clinical management of anti-Kell alloimmunization in pregnancy

Received 2 April 2005 ,Revised 13 March 2007 ,Accepted 16 March 2007.

References 

  1. Geifman-Holtzman O, Wojtowycz M, Kosmas E, Artal R. Female alloimmunization with antibodies known to cause hemolytic disease. Obstet Gynecol. 1997;89(2):272–275
  2. Caine ME, Mueller-Heubach E. Kell sensitization in pregnancy. Am J Obstet Gynecol. 1986;154(1):85–90
  3. Mayne KM, Bowell PJ, Pratt GA. The significance of anti-Kell sensitization in pregnancy. Clin Lab Haematol. 1990;12(4):379–385
  4. Grant SR, Kilby MD, Meer L, Weaver JB, Gabra GS, Whittle MJ. The outcome of pregnancy in Kell alloimmunisation. BJOG. 2000;107(4):481–485
  5. Moise KJ. Non-anti-D antibodies in red-cell alloimmunization. Eur J Obstet Gynecol Reprod Biol. 2000;92(1):75–81
  6. Freire-Lizama T, Oepkes D. Management of Kell alloimmunized pregnancies. Fetal Mater Med Rev. 2002;13(02):87–102
  7. Vaughan JI, Warwick R, Letsky E, Nicolini U, Rodeck CH, Fisk NM. Erythropoietic suppression in fetal anemia because of Kell alloimmunization. Am J Obstet Gynecol. 1994;171(1):247–252
  8. Vaughan JI, Manning M, Warwick RM, Letsky EA, Murray NA, Roberts IA. Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia. N Engl J Med. 1998;338(12):798–803
  9. Weiner CP, Widness JA. Decreased fetal erythropoiesis and hemolysis in Kell hemolytic anemia. Am J Obstet Gynecol. 1996;174(2):547–551
  10. Berkowitz RL, Beyth Y, Sadovsky E. Death in utero due to Kell sensitization without excessive elevation of the delta OD450 value in amniotic fluid. Obstet Gynecol. 1982;60(6):746–749
  11. Babinszki A, Lapinski RH, Berkowitz RL. Prognostic factors and management in pregnancies complicated with severe kell alloimmunization: experiences of the last 13 years. Am J Perinatol. 1998;15(12):695–701
  12. Freire-Lizama T, Oepkes D, Denomme G, Seaward G, Fernandes B, Ryan G. The value of serial antibody titre assessment in Kell alloimmunized pregnancies (abstract). Am J Obstet Gynecol. 2001;184:132
  13. Mari G, Deter RL, Carpenter RL, et al. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses. N Engl J Med. 2000;342(1):9–14
  14. Mandelbrot L, Daffos F, Forestier F, MacAleese J, Descombey D. Assessment of fetal blood volume for computer-assisted management of in utero transfusion. Fetal Ther. 1988;3(1/2):60–66
  15. Farr V, Gray E. Pregnancy outcome in mothers who develop Kell antibodies. Scott Med J. 1988;33(4):300–303
  16. Leggat HM, Gibson JM, Barron SL, Reid MM. Anti-Kell in pregnancy. Br J Obstet Gynaecol. 1991;98(2):162–165
  17. Van Selm M, Kanhai HH, Van Loon AJ. Detection of fetomaternal haemorrhage associated with cordocentesis using serum alpha-fetoprotein and the Kleihauer technique. Prenat Diagn. 1995;15(4):313–316
  18. Chitrit Y, Caubel P, Lusina D, et al. Detection and measurement of fetomaternal hemorrhage following diagnostic cordocentesis. Fetal Diagn Ther. 1998;13(4):253–256
  19. Alshimmiri MM, Hamoud MS, Al-Saleh EA, Mujaibel KY, Al-Harmi JA, Thalib L. Prediction of fetal anemia by middle cerebral artery peak systolic velocity in pregnancies complicated by rhesus isoimmunization. J Perinatol. 2003;23(7):536–540
  20. Collinet P, Subtil D, Puech F, Vaast P. Successful treatment of extremely severe fetal anemia due to Kell alloimmunization. Obstet Gynecol. 2002;100(5Pt2):1102–1105

PII: S0301-2115(07)00127-3

doi: 10.1016/j.ejogrb.2007.03.003

European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 136, Issue 2 , Pages 151-154 , February 2008

Article Tools

* Image Usage & Resolution